BTLA-mediated regulation of neuroimmune responses enhances recovery after intracerebral hemorrhage
Authors:
Open Access
- 23 January 2026
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1)
Abstract
Modulating harmful neuroimmune responses is a promising therapeutic approach for hemorrhagic stroke, a condition that still lacks effective treatment. TheKeywords
Funding Information
- The Well-Known Physician Project and the Outstanding Foreign Scientist Workshop in Henan province (GZS2024022)
This publication has 64 references indexed in Scilit:
- Spatiotemporal transcriptomic maps of mouse intracerebral hemorrhage at single-cell resolutionNeuron, 2025
- Inflammation in intracerebral hemorrhage: A bibliometric perspectiveBrain Hemorrhages, 2024
- CD22 blockade modulates microglia activity to suppress neuroinflammation following intracerebral hemorrhagePharmacological Research, 2023
- Neuroinflammation in Acute Ischemic and Hemorrhagic StrokeCurrent Neurology and Neuroscience Reports, 2023
- T-cell receptor signaling modulated by the co-receptors: Potential targets for stroke treatmentPharmacological Research, 2023
- Systemic innate myeloid responses to acute ischaemic and haemorrhagic strokeSeminars in Immunopathology, 2022
- Time for a New Perspective on Intracerebral HemorrhageJAMA Neurology, 2022
- Exploring the VISTA of microglia: immune checkpoints in CNS inflammationJournal of Molecular Medicine, 2020
- Microglial Depletion with Clodronate Liposomes Increases Proinflammatory Cytokine Levels, Induces Astrocyte Activation, and Damages Blood Vessel IntegrityMolecular Neurobiology, 2019
- Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variantsImmunobiology, 2010